In conclusion, the current study identified 3 miRNA-related SNPs in the PI3K/Akt/mTOR pathway as prognostic biomarkers for patients with limited-disease SCLC treated with chemoradiotherapy. This evidence concerns the gene MTOR and small cell lung carcinoma.